Clinical Trial Update: TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant [NA]

View source ↗

Summary

A clinical trial evaluating TCRαβ/CD19-depleted stem cell grafts for transplantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Graft-versus-host Disease
• Hematologic Malignancy
• Non-hematologic Malignancy

Snippet

Sponsor: Neena Kapoor, M.D. | Conditions: Graft Vs Host Disease, Graft-versus-host-disease | NA | Status: WITHDRAWN